New Non-Drug Relief for Migraines

Thursday, 07 Feb 2013 12:10 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
A nerve stimulator placed on the forehead may help prevent migraines among some people who get the headaches regularly — and it appears to be safe, according to a new trial.
Researchers found that people who used the stimulation devices for a short period every day over three months had fewer headaches than those who used a "sham" stimulator.
But the lead author of the study called the difference "not overwhelming."
"There's no universally effective therapy for migraine," said Dr. Joel Saper, from the Michigan Head-Pain and Neurological Institute in Ann Arbor.
"Therefore, we need options, many options. There may be another option here which could be of value," Saper, who wasn't involved in the new research, told Reuters Health.
The headband-like devices used in the study, made by STX-Med, were donated by the company. In Belgium, where the trial was conducted, they run for about 300 Euros — or just over $400, said lead author Dr. Jean Schoenen, from Liege University.
According to a company representative, the device, known as Cefaly, was submitted to the U.S. Food and Drug Administration but has not yet been approved.
Schoenen and his colleagues treated 67 migraine sufferers with the electrical nerve stimulator or an identical sham stimulator for 20 minutes every day for three months.
During that time, average monthly migraines fell from seven to five among study volunteers treated with stimulation, but held steady between six and seven in the sham comparison group.
Thirty-eight percent of headache sufferers in the nerve stimulation group had their number of monthly migraines at least cut in half, compared to 12 percent of sham-treated subjects.
"The effects are clear, but modest," Schoenen told Reuters Health.
He said there are medications, such as topiramate (marketed as Topamax), that have better results than nerve stimulation — but they also come with a number of side effects.
Stimulation, on the other hand, wasn't linked to any serious side effects in the new study, published Wednesday in Neurology.
Saper said he and his colleagues use this type of nerve stimulation in their practice. The device transmits electrical signals through electrodes placed on the forehead, above the eyes, to stimulate a major facial nerve called the trigeminal.
"We have a certain number of our patients who benefit from that," he said. "But equally, a person with the same kind of headache … won't respond to it."
People in the trial were average migraine patients who got one or two headaches per week, Schoenen noted.
"There is no proof at this time that this device is also effective in people with very severe or very frequent migraine attacks," he said.
"Those migraines patients who are very disabled, they should first be treated with the more effective drug treatments," such as topiramate.
The device can be used at home while people watch television, read or do housework, Schoenen said, so using it for 20 minutes each day isn't too burdensome.
 
Because it won't work for everyone, he recommends migraine sufferers who are interested in trying nerve stimulation rent the device for a couple of months before buying one
 
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Top Ebola Doctor Dies From the Disease, Hailed as Hero

Tuesday, 29 Jul 2014 16:13 PM

A leading virologist who risked his own life to treat dozens of Ebola patients died Tuesday from the disease, officials  . . .

New Cholesterol Drug Found to Work Better Than Statins

Wednesday, 30 Jul 2014 08:32 AM

A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut bad LDL cholesterol more than pla . . .

Dieting at Young Age Often Backfires

Wednesday, 30 Jul 2014 08:21 AM

Dieting at a young age might set the stage for harmful health habits, including eating disorders, according to new resea . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved